Temozolomide is a crucial chemotherapy drug used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, two aggressive brain cancers. As a leading Temozolomide manufacturer, we ensure the production of high-quality medication that meets global regulatory standards.



This oral alkylating agent works by damaging cancer cell DNA, preventing tumor growth. Its ability to cross the blood-brain barrier makes it highly effective in brain cancer treatment. Temozolomide is often used alongside radiation therapy to enhance therapeutic outcomes. While generally well-tolerated, some patients may experience side effects such as nausea, fatigue, and lowered blood cell counts.



As a trusted Temozolomide manufacturer, we follow Good Manufacturing Practices (GMP) and strict quality control measures to deliver a safe and effective product. Our advanced manufacturing facilities ensure the production of Temozolomide in various strengths, including 5 mg, 20 mg, 100 mg, and 250 mg capsules, providing flexible treatment options.